Effect of Iberogast (STW5) on tolerance to colonic gas in patients with irritable bowel syndrome: A randomized, double‐blind, placebo control clinical trial.

MLA

Aguilar, Ariadna, et al. “Effect of Iberogast (STW5) on Tolerance to Colonic Gas in Patients with Irritable Bowel Syndrome: A Randomized, Double‐blind, Placebo Control Clinical Trial.” Neurogastroenterology & Motility, vol. 36, no. 10, Oct. 2024, pp. 1–8. EBSCOhost, https://doi.org/10.1111/nmo.14765.

APA

Aguilar, A., Benslaiman, B., & Serra, J. (2024). Effect of Iberogast (STW5) on tolerance to colonic gas in patients with irritable bowel syndrome: A randomized, double‐blind, placebo control clinical trial. Neurogastroenterology & Motility, 36(10), 1–8. https://doi.org/10.1111/nmo.14765

Chicago

Aguilar, Ariadna, Bouchra Benslaiman, and Jordi Serra. 2024. “Effect of Iberogast (STW5) on Tolerance to Colonic Gas in Patients with Irritable Bowel Syndrome: A Randomized, Double‐blind, Placebo Control Clinical Trial.” Neurogastroenterology & Motility 36 (10): 1–8. doi:10.1111/nmo.14765.